Molecular and Therapeutic Potential and Toxicity of Yalproic AcidCHATEAUVIEUX, Sébastien; MORCEAU, Franck; DICATO, Mario et al.Journal of Biomedicine and Biotechnology (Print). 2010, Vol 2010, issn 1110-7243, 479364.1-479364.18, 3Article

Tumor necrosis factor alpha-mediated inhibition of erythropoiesis involves GATA-1/GATA-2 balance impairment and PU.1 over-expressionGRIGORAKAKI, Christine; MORCEAU, Franck; CHATEAUVIEUX, Sébastien et al.Biochemical pharmacology. 2011, Vol 82, Num 2, pp 156-166, issn 0006-2952, 11 p.Article

Valproic acid perturbs hematopoietic homeostasis by inhibition of erythroid differentiation and activation of the myelo-monocytic pathwayCHATEAUVIEUX, Sébastien; EIFES, Serge; MORCEAU, Franck et al.Biochemical pharmacology. 2011, Vol 81, Num 4, pp 498-509, issn 0006-2952, 12 p.Article

Tumor necrosis factor a inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulationBUCK, Isabelle; MORCEAU, Franck; CRISTOFANON, Silvia et al.Biochemical pharmacology. 2008, Vol 76, Num 10, pp 1229-1239, issn 0006-2952, 11 p.Article

Heteronemin, a spongean sesterterpene, inhibits TNFα-induced NF-_KB activation through proteasome inhibition and induces apoptotic cell deathSCHUMACHER, Marc; CERELLA, Claudia; EIFES, Serge et al.Biochemical pharmacology. 2010, Vol 79, Num 4, pp 610-622, issn 0006-2952, 13 p.Article